Posted February 13, 2009
Whopper of a merger for Wyeth, Pfizer – but questionable long-term value
By SIMON KING, Datamonitor
Analysis: Pfizer’s acquisition of Wyeth immediately brings scale but will fail to deliver sustainable sales growth. Copyright 2013 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Log in or upgrade to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.